Navigation Links
Genetic Research Sheds Light on Adrenal Gland Tumor Risk
Date:12/14/2010

TUESDAY, Dec. 14 (HealthDay News) -- Scientists report that they have advanced their knowledge of genetic mutations associated with adrenal gland tumors by identifying 13 new potential variations.

Tumors called pheochromocytomas can affect the adrenal gland, which is located above the kidney. These tumors -- which are usually benign but can also be cancerous -- cause the adrenal gland to produce too much adrenaline, resulting in high blood pressure, headaches, heart palpitations, nausea and vomiting.

In the new study, which included nearly 1,000 people, the researchers identified 19 mutations in the FP/TMEM127 gene that may be associated with pheochromocytomas in the adrenal gland.

"Of these, 19 mutations found in 20 patients were considered of potential pathogenic significance. Thirteen of these variants were [new], while the remainder had been previously reported," Li Yao, of the University of Texas Health Science Center at San Antonio, and colleagues wrote in the report published in the Dec. 15 issue of the Journal of the American Medical Association.

The average age of patients when they developed FP/TMEM127-mutated tumors was 42.8 years and median (midpoint) age was 41.5 years.

"These observations support the existence of additional pheochromocytoma susceptibility genes, which may account for some of the genetically undefined cases," the authors wrote in a news release from the journal's publisher.

More information

The American Urological Association has more about pheochromocytoma.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, Dec. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Rare Genetic Syndrome May Increase Colon Cancer Risk
2. Chinese Study Suggests New Way to Test for Genetic Diseases
3. New discovery prevents symptoms of rare genetic disorder
4. Genetic mutations associated with increased PSA and prostate cancer
5. Novel genetic mutation that causes the most common form of eye cancer discovered
6. Rare, Severe Form of Morning Sickness Appears to Be Genetic
7. Our normal genetics may influence cancer growth, too
8. Academies of science call for amendments to impracticable Genetic Diagnostics Act
9. New research shows genetic test for lung cancer risk prompts smokers to quit
10. Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia
11. ASHG 2010: New research on implications of direct-to-consumer and clinical genetic testing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Research Sheds Light on Adrenal Gland Tumor Risk
(Date:7/25/2017)... MOORE, OK (PRWEB) , ... July 25, 2017 ... ... are proud to announce the launch of their partnership to provide the ... is the first pharmacy-focused platform in the country with the ability to develop ...
(Date:7/25/2017)... ... 25, 2017 , ... Dr. Donna Bergman, professor of education ... published an article in the medical science journal Physical Medicine and Rehabilitation titled ... and the research that helped produce it, were written and conducted in collaboration ...
(Date:7/25/2017)... ... 2017 , ... Facing medical needs with a newborn boy this spring, ... new benefit for employees that is uncommon in American business: 12 weeks of fully ... and other employees as new parents. It keeps our family life more stable. I ...
(Date:7/24/2017)... ... ... Engineers at the University of Maryland have invented an entirely new kind of ... the body uses. , In ordinary batteries the electrical energy, or current, delivered ... battery is generated by moving positive ions from one end to the other of ...
(Date:7/24/2017)... ... July 24, 2017 , ... SignatureCare Emergency Center is ... for the fall semester to a deserving student. Get your applications in now ... was awarded to Mariana Castillo who is a nursing student at Prairie View A&M ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology: